Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 12:23 PM
Ignite Modification Date: 2025-12-25 @ 12:03 PM
NCT ID: NCT05064761
Description: None
Frequency Threshold: 0
Time Frame: Up to 12 months
Study: NCT05064761
Study Brief: Safety and Effectiveness of Poly-l-lactic Acid (PLLA) for the Improvement in Appearance of Cellulite
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Treatment Group (Sculptra) Participants with intent to undergo treatment to improve appearance of cellulite were enrolled and treated with Sculptra in three sessions spaced one month (+2 weeks) apart. Participants were treated at baseline, Month 1 and Month 2. 0 None 0 29 10 29 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Nasopharyngitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (24.1) View
Intervertebral disc protrusion SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (24.1) View
Bronchitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (24.1) View
COVID-19 SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (24.1) View
Sinusitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (24.1) View
Urinary tract infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (24.1) View
Urethral prolapse SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA (24.1) View